2nd Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.

Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.

LobbyistCovered position, as disclosed
CHRISTINA HOCHUL —
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 990 (116th), S. 440 (116th), S. 344 (116th)

Medicare/Medicaid MMM

Medicare Part B drugs payments and access. S. 551, the REFUND Act.

Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 551 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.